Excelsior Biopharma Inc.
6496
Rank in Stocks
#24324
Excelsior Biopharma Inc., established in 1988 and headquartered in Taipei,... Excelsior Biopharma Inc., established in 1988 and headquartered in Taipei, Taiwan, functions as a pharmaceutical enterprise with a global market presence, encompassing Taiwan, China, and other international regions. The company offers a comprehensive range of healthcare solutions, including prescription and over-the-counter medications, medical devices, nutritional supplements, and various medical supplies. Excelsior addresses numerous therapeutic areas such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, otorhinolaryngology, and infectious disease management. Its product line also features specialized diagnostic kits under the Actim brand for identifying conditions like influenza virus, fecal occult blood, acute pancreatitis, and for assessing preterm or full-week delivery and early membrane rupture. Moreover, the company provides oral hygiene products, including toothpaste, mouthwash, and gels, under the Oral7 name. Beyond product sales, Excelsior is involved in the import and export of active pharmaceutical ingredients, as well as engaging in technological research, facilitating pharmaceutical technology transfer, and participating in collaborative development and improvement initiatives. The company adopted its current name, Excelsior Biopharma Inc., in June 2003, having previously been known as Excelsior Enterprise Co., Ltd.
Share Price
$0.73315123
Last synced: 2026-11-10
Market Cap
$34.07M
Change (1 day)
0.84%
Change (1 year)
-22.58%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Excelsior Biopharma Inc. (6496)
Category
Healthcare
EPS for Excelsior Biopharma Inc. (6496)
EPS as of September 2026 TTM: $-0.12
According to Excelsior Biopharma Inc.'s latest financial reports, its current EPS (TTM) is $-0.12. At the end of 2025 the company had an EPS of $-0.13, a decrease compared to its 2024 EPS of $-0.07.
EPS history for Excelsior Biopharma Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.12 | -5.46% |
| 2025 | $-0.13 | 94.02% |
| 2024 | $-0.07 | 1.09% |
| 2023 | $-0.06 | 174.47% |
| 2022 | $-0.02 | 91.06% |
| 2021 | $-0.01 | -145.39% |
| 2020 | $0.03 | -46.65% |
| 2019 | $0.05 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -5,389.99% |
DE
|
|
| $6.08 | -5,045.16% |
DE
|
|
| $1.55 | -1,361.68% |
JP
|
|
| $3.66 | -3,078.03% |
CH
|
|
| $0.45 | -466.15% |
IL
|
Questions about Excelsior Biopharma Inc.'s earnings per share (EPS)
What is Excelsior Biopharma Inc.'s earnings per share (EPS)?
Excelsior Biopharma Inc.'s earnings per share (EPS) over the last twelve months is $-0.12, as of Sep 2026.
What was Excelsior Biopharma Inc.'s earnings per share (EPS) in 2025?
In 2025, Excelsior Biopharma Inc.'s earnings per share (EPS) was $-0.13, compared with $-0.07 in 2024.
How has Excelsior Biopharma Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Excelsior Biopharma Inc.'s earnings per share (EPS) was highest in 2020 ($0.03) and lowest in 2025 ($-0.13).
How does Excelsior Biopharma Inc.'s earnings per share (EPS) compare with similar companies?
Excelsior Biopharma Inc.'s earnings per share (EPS) ($-0.12) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.